Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia

As effective therapies for relapse and refractory B-cell acute lymphoblastic leukemia (B-ALL) remain problematic, novel therapeutic strategies are needed. Artemis is a key endonuclease in V(D)J recombination and nonhomologous end joining (NHEJ) of DNA double-strand break (DSB) repair. Inhibition of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogana, Heather A., Hurwitz, Samantha, Hsieh, Chih-Lin, Geng, Huimin, Müschen, Markus, Bhojwani, Deepa, Wolf, Mark A., Larocque, James, Lieber, Michael R., Kim, Yong Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111164/
https://www.ncbi.nlm.nih.gov/pubmed/37082620
http://dx.doi.org/10.3389/fcell.2023.1134121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111164/
https://www.ncbi.nlm.nih.gov/pubmed/37082620
http://dx.doi.org/10.3389/fcell.2023.1134121

Ejemplares similares